Trial intelligence / Profile preview

Dronabinol on Behavioural Responses to Food Images and Food Intake

NCT02310347Active, not recruiting

Sponsor
UZ Leuven
Start
Dec 2014
Primary completion
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Trial of dronabinol in functional dyspepsia (FD) and obesity (2 arms), sponsored by UZ Leuven. Primary endpoints: Behavioural responses to food images and food intake at 2 years and Gut peptide responses at 2 years. Started Dec 2014; status: active, not recruiting.

02

Drugs

dronabinol
03

Conditions

functional dyspepsia (FD)obesity

Beyond the preview

Go deeper on NCT02310347.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02310347.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call